Texas Halo Fund

Texas Halo Fund, established in 2012 and headquartered in Houston, Texas, is an investment company that focuses on early-stage venture capital. It manages multiple funds, each with a distinct investment focus, including healthcare, information technology, software, life science, and consumer products. The firm seeks compelling investment opportunities across various industries and geographies, aiming to generate high returns with low risk for its investors. It typically invests in 20-25 companies per fund, with an investment horizon of 5 to 7 years.

Kyra Doolan

Managing Director, Funds II, III and IV

Kevin King

Managing Director, Funds II, III and IV

Christy Luquire

Managing Director

Christina Luquire

Managing Director and Fund I Deal Committee Member

Bill Wheelock

Managing Director

Past deals in Texas

Dynamic Light

Convertible Note in 2022
Dynamic Light, established in May 2018 and based in Austin, Texas, specializes in advanced blood flow imaging technology aimed at enhancing patient care and reducing healthcare costs. The company’s innovative solution enables real-time, continuous, and quantitative visualization of blood flow in living tissues, allowing surgeons to make informed decisions during procedures. By providing high-resolution imaging without the need for dyes or procedural interruptions, Dynamic Light's technology supports improved surgical outcomes and patient management.

Galen Data

Series A in 2021
Galen Data, Inc. is a healthcare technology company based in Houston, Texas, founded in 2016. It offers a cloud-based software platform designed for medical devices, enabling them to centralize and securely store data while leveraging cloud technologies. The platform is FDA-compliant and HITRUST-certified, integrating seamlessly with major electronic health record systems. Galen Data provides tools for data visualization and analytics, which help healthcare providers track patient compliance and optimize information management. By maintaining the necessary infrastructure and ensuring compliance with cybersecurity and global regulations, the company allows medical device companies to focus on their core innovations without needing expertise in software design or data management. This approach offers significant time and cost savings, as well as reduced risk in bringing medical devices to market.

Ikonopedia

Series D in 2021
Ikonopedia, LLC specializes in developing a cloud-based breast study interpretation and reporting system aimed at enhancing the workflows of radiologists. Established in 2012 and headquartered in Dallas, Texas, the company provides a comprehensive Mammography Reporting System that generates structured, MQSA-compliant reports tailored to individual radiologists, as well as SonoPro, a web application designed to assist radiologists during diagnostic breast ultrasound exams. Ikonopedia's solutions are utilized in telemammography and satellite clinics, featuring capabilities such as automated patient tracking and monitoring to ensure comprehensive care. The system supports patient letters and questionnaires in multiple languages and is designed to be compatible with modern devices. By prioritizing clear and consistent clinical reporting, Ikonopedia aims to enhance patient safety, reduce errors, and ensure compliance with industry standards, ultimately contributing to improved health outcomes for women.

VenoStent

Seed Round in 2021
VenoStent, Inc. is a clinical-stage tissue engineering company based in Nashville, Tennessee, with an additional office in Houston, Texas. Founded in 2017, it specializes in the development of bioresorbable smart polymers designed to enhance vascular surgery outcomes. The company’s primary product, SelfWrap, is a perivascular wrap that functions as an external stent, providing mechanical support to veins and promoting outward growth. This innovative technology aims to reduce complications at the vein-artery junction in dialysis patients, particularly by minimizing vein collapse and improving the usability of arteriovenous fistulas (AVF). By utilizing a new class of shape-memory polymers that do not require sutures, VenoStent's approach reduces surgery time and lowers the risk of infection, ultimately enhancing the quality and length of life for patients with chronic kidney disease undergoing hemodialysis.

Allotrope Medical

Series A in 2021
Allotrope Medical Inc. is a Houston-based medical device company focused on enhancing surgical procedures by developing innovative devices for ureter identification. The company's flagship product, the StimSite, is an intuitive handheld device that aids surgeons in quickly and accurately locating ureters during pelvic surgeries. This device features a simple design with a single button, eliminating the need for complex pre- and post-operative procedures. Founded in 2016, Allotrope Medical aims to improve surgical outcomes by providing tools that streamline the identification and localization of ureters, thus facilitating safer and more efficient operations.

Allotrope Medical

Convertible Note in 2020
Allotrope Medical Inc. is a Houston-based medical device company focused on enhancing surgical procedures by developing innovative devices for ureter identification. The company's flagship product, the StimSite, is an intuitive handheld device that aids surgeons in quickly and accurately locating ureters during pelvic surgeries. This device features a simple design with a single button, eliminating the need for complex pre- and post-operative procedures. Founded in 2016, Allotrope Medical aims to improve surgical outcomes by providing tools that streamline the identification and localization of ureters, thus facilitating safer and more efficient operations.

VenoStent

Seed Round in 2020
VenoStent, Inc. is a clinical-stage tissue engineering company based in Nashville, Tennessee, with an additional office in Houston, Texas. Founded in 2017, it specializes in the development of bioresorbable smart polymers designed to enhance vascular surgery outcomes. The company’s primary product, SelfWrap, is a perivascular wrap that functions as an external stent, providing mechanical support to veins and promoting outward growth. This innovative technology aims to reduce complications at the vein-artery junction in dialysis patients, particularly by minimizing vein collapse and improving the usability of arteriovenous fistulas (AVF). By utilizing a new class of shape-memory polymers that do not require sutures, VenoStent's approach reduces surgery time and lowers the risk of infection, ultimately enhancing the quality and length of life for patients with chronic kidney disease undergoing hemodialysis.

Galen Data

Seed Round in 2019
Galen Data, Inc. is a healthcare technology company based in Houston, Texas, founded in 2016. It offers a cloud-based software platform designed for medical devices, enabling them to centralize and securely store data while leveraging cloud technologies. The platform is FDA-compliant and HITRUST-certified, integrating seamlessly with major electronic health record systems. Galen Data provides tools for data visualization and analytics, which help healthcare providers track patient compliance and optimize information management. By maintaining the necessary infrastructure and ensuring compliance with cybersecurity and global regulations, the company allows medical device companies to focus on their core innovations without needing expertise in software design or data management. This approach offers significant time and cost savings, as well as reduced risk in bringing medical devices to market.

Zibrio

Convertible Note in 2019
Zibrio is a balance diagnostics company based in Houston, Texas, that was established in 2017. The company specializes in a technology that utilizes insights from postural control and machine learning to detect subtle changes in balance. Originally developed from NASA technology designed for astronauts returning from space, Zibrio's device aims to empower individuals to take charge of their health. By measuring balance and weight, it helps users understand their balance profiles and offers guidance for improvement. The company's mission is to enhance health outcomes, reduce the risk of falls, and promote overall balance and well-being.

Allotrope Medical

Convertible Note in 2019
Allotrope Medical Inc. is a Houston-based medical device company focused on enhancing surgical procedures by developing innovative devices for ureter identification. The company's flagship product, the StimSite, is an intuitive handheld device that aids surgeons in quickly and accurately locating ureters during pelvic surgeries. This device features a simple design with a single button, eliminating the need for complex pre- and post-operative procedures. Founded in 2016, Allotrope Medical aims to improve surgical outcomes by providing tools that streamline the identification and localization of ureters, thus facilitating safer and more efficient operations.

VenoStent

Pre Seed Round in 2019
VenoStent, Inc. is a clinical-stage tissue engineering company based in Nashville, Tennessee, with an additional office in Houston, Texas. Founded in 2017, it specializes in the development of bioresorbable smart polymers designed to enhance vascular surgery outcomes. The company’s primary product, SelfWrap, is a perivascular wrap that functions as an external stent, providing mechanical support to veins and promoting outward growth. This innovative technology aims to reduce complications at the vein-artery junction in dialysis patients, particularly by minimizing vein collapse and improving the usability of arteriovenous fistulas (AVF). By utilizing a new class of shape-memory polymers that do not require sutures, VenoStent's approach reduces surgery time and lowers the risk of infection, ultimately enhancing the quality and length of life for patients with chronic kidney disease undergoing hemodialysis.

Ikonopedia

Series C in 2019
Ikonopedia, LLC specializes in developing a cloud-based breast study interpretation and reporting system aimed at enhancing the workflows of radiologists. Established in 2012 and headquartered in Dallas, Texas, the company provides a comprehensive Mammography Reporting System that generates structured, MQSA-compliant reports tailored to individual radiologists, as well as SonoPro, a web application designed to assist radiologists during diagnostic breast ultrasound exams. Ikonopedia's solutions are utilized in telemammography and satellite clinics, featuring capabilities such as automated patient tracking and monitoring to ensure comprehensive care. The system supports patient letters and questionnaires in multiple languages and is designed to be compatible with modern devices. By prioritizing clear and consistent clinical reporting, Ikonopedia aims to enhance patient safety, reduce errors, and ensure compliance with industry standards, ultimately contributing to improved health outcomes for women.

TeVido BioDevices

Venture Round in 2019
TeVido BioDevices, Inc. is a biotechnology start-up based in Austin, Texas, focused on developing innovative tissue-engineered products for reconstructive surgery. Founded in 2016, the company utilizes a platform technology that combines 3D bio-printing with a patient's living cells to create custom grafts. These grafts specifically address the needs of individuals who have lost skin color due to scarring or disease, offering improved options for reconstruction. TeVido's technology not only aims to restore lost pigment but also has potential applications in wound healing and cosmetic surgery, ultimately enhancing patient outcomes and quality of life.

ClearCam

Seed Round in 2018
ClearCam Inc. is a medical technology company based in Austin, Texas, founded in 2018. The company specializes in manufacturing a laparoscopic lens cleaner device known as ClearCam Kelling, which is designed to enhance the visual field for surgeons during laparoscopic procedures. This innovative device allows for intra-operative lens cleaning without the need to remove the laparoscope from the body cavity, thereby streamlining surgical processes and improving safety. By eliminating the requirement for additional supplies, ClearCam's technology contributes to reduced procedure time, benefiting patients, surgeons, and surgical staff alike.

TeVido BioDevices

Seed Round in 2018
TeVido BioDevices, Inc. is a biotechnology start-up based in Austin, Texas, focused on developing innovative tissue-engineered products for reconstructive surgery. Founded in 2016, the company utilizes a platform technology that combines 3D bio-printing with a patient's living cells to create custom grafts. These grafts specifically address the needs of individuals who have lost skin color due to scarring or disease, offering improved options for reconstruction. TeVido's technology not only aims to restore lost pigment but also has potential applications in wound healing and cosmetic surgery, ultimately enhancing patient outcomes and quality of life.

DNAtrix

Convertible Note in 2016
DNAtrix, Inc. is a clinical-stage biotechnology company based in Texas that specializes in developing virus-driven immunotherapies for cancer treatment. The company’s leading product, DNX-2401, is an oncolytic immunotherapy designed to target and kill glioblastoma cells, a particularly aggressive form of brain cancer. This therapy has shown promising early results, with over 35 patients treated. DNAtrix is also developing additional armed DNX viruses, specifically DNX-2440 and DNX-2450, aimed at treating various solid tumors, as well as MYX-135, which targets hematological malignancies. With a focus on harnessing modified viruses to selectively destroy cancer cells while stimulating the immune system, DNAtrix seeks to expand its platform to address other cancers, including brain metastases, ovarian, and pancreatic cancers. The company was incorporated in 2005 and maintains its headquarters in Houston, Texas, with an additional office in San Diego, California.

Infrastructure Networks

Venture Round in 2016
Infrastructure Networks provides services for the acquisition and delivery of natural energy resources required to power a modern economy. It eliminates the frustrations associated with managing and scaling remote communications by providing end-to-end customer connectivity solutions. By leveraging the global scale and adoption of a leading standards-compliant technology, recognized technology leaders, along with 24/7 monitoring and boots-on-ground service, INET delivers “Wireless Infrastructure-as-a-Service” (W-Iaas) over the industry’s first end-to-end, private, LTE network. The company was founded in 2011 and is based in Houston, Texas.

Adient Medical

Series C in 2016
Adient Medical Inc. is a company specializing in the development and delivery of implantable and absorbable medical devices, primarily focused on preventing pulmonary embolisms. Founded in 2012 and headquartered in Pearland, Texas, Adient Medical aims to create devices that are safe and effective throughout their intended use, and then naturally dissolve without the need for surgical removal. This innovative approach not only enhances patient safety but also reduces the potential for complications and the costs associated with removal procedures. Through its absorbable vascular filter, Adient Medical provides healthcare professionals with a safer alternative for managing the risk of pulmonary embolism in patients.

Adient Medical

Seed Round in 2015
Adient Medical Inc. is a company specializing in the development and delivery of implantable and absorbable medical devices, primarily focused on preventing pulmonary embolisms. Founded in 2012 and headquartered in Pearland, Texas, Adient Medical aims to create devices that are safe and effective throughout their intended use, and then naturally dissolve without the need for surgical removal. This innovative approach not only enhances patient safety but also reduces the potential for complications and the costs associated with removal procedures. Through its absorbable vascular filter, Adient Medical provides healthcare professionals with a safer alternative for managing the risk of pulmonary embolism in patients.

Set.fm

Convertible Note in 2015
Set.fm, Inc. operates an online platform designed for live concert performers, enabling them to capture and sell recordings of their performances immediately after the show. Founded in 2012 and based in Austin, Texas, Set.fm offers a user-friendly mobile application that allows musicians to record audio with or without an interface, facilitating the sale of their live sets directly to fans. This service provides artists with an additional revenue stream while allowing audiences to relive their concert experiences shortly after the event concludes. Formerly known as DejaSet, Inc., the company changed its name in July 2013 and has since become a subsidiary of VNUE, Inc.

DNAtrix

Series B in 2014
DNAtrix, Inc. is a clinical-stage biotechnology company based in Texas that specializes in developing virus-driven immunotherapies for cancer treatment. The company’s leading product, DNX-2401, is an oncolytic immunotherapy designed to target and kill glioblastoma cells, a particularly aggressive form of brain cancer. This therapy has shown promising early results, with over 35 patients treated. DNAtrix is also developing additional armed DNX viruses, specifically DNX-2440 and DNX-2450, aimed at treating various solid tumors, as well as MYX-135, which targets hematological malignancies. With a focus on harnessing modified viruses to selectively destroy cancer cells while stimulating the immune system, DNAtrix seeks to expand its platform to address other cancers, including brain metastases, ovarian, and pancreatic cancers. The company was incorporated in 2005 and maintains its headquarters in Houston, Texas, with an additional office in San Diego, California.

Deep Imaging Technologies

Venture Round in 2014
Deep Imaging Technologies, Inc. is a subsurface imaging company established in 2008 and located in Tomball, Texas. The company specializes in developing advanced data collection equipment and software technologies tailored for the oil and gas industry. Its product offerings include surface imaging systems that utilize electromagnetic fields generated at very low frequencies to effectively image geological features. The combination of transmitters, receivers, and imaging software positions Deep Imaging Technologies as a key player in enhancing subsurface data acquisition and interpretation within the sector.

Cinegif

Seed Round in 2013
Cinegif is a software development company based in Austin, Texas, specializing in a patented video conversion technology that simplifies the creation of animated GIFs. This platform allows marketers and advertisers to transform still images and videos into engaging animated content, facilitating storytelling and communication without the complexities and high costs associated with traditional video. Cinegif's solutions are utilized by branding professionals, email marketing firms, and web hosting companies to enhance customer engagement across various digital channels, including websites, email, social media, text messaging, and digital signage. By providing a user-friendly tool for GIF marketing, Cinegif helps product-based organizations effectively connect with their target audiences.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.